• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD63高表达的巨噬细胞来源外泌体miR-6876-5p通过PTEN/Akt介导的上皮-间质转化途径促进肝癌干性。

CD63-high macrophage-derived exosomal miR-6876-5p promotes hepatocellular carcinoma stemness via PTEN/Akt-mediated EMT pathway.

作者信息

Zhang Shuairan, Liu Shiqi, Dong Hang, Jin Xiuli, Sun Jing, Sun Ji, Wu Gang, Li Yiling

机构信息

Department of Gastroenterology, The First Hospital of China Medical University, Shenyang, PR China.

Department of Hepatobiliary Surgery, The First Hospital of China Medical University, Shenyang, PR China.

出版信息

Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000616. eCollection 2025 Jan 1.

DOI:10.1097/HC9.0000000000000616
PMID:39774566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11717501/
Abstract

OBJECTIVE

Accumulating evidence suggests that microRNAs derived from macrophage exosomes can regulate the stemness and progression of cancer. However, the interaction mechanisms between HCC cells and tumor-associated macrophages remain unclear.

METHODS

Exosomes were extracted from control or CD63 overexpression macrophages and co-cultured with HCC cells. The stemness, proliferation, epithelial-mesenchymal transition, and in vivo tumorigenicity of HCC cells were assessed to determine the role of CD63-high macrophage-derived exosomal miR-6876-5p in HCC. The binding relationship between miR-6876-5p and the PTEN/Akt axis was also investigated.

RESULTS

Elevated CD63 expression was associated with increased tumor-associated macrophage infiltration and poorer prognosis in HCC. CD63-high macrophage-derived exosomes enhanced HCC cell proliferation, stemness, and epithelial-mesenchymal transition. miR-6876-5p within these exosomes was identified as a key mediator, promoting HCC progression by targeting PTEN and activating the Akt signaling pathway. In vivo studies confirmed that CD63-high macrophage-derived exosomal miR-6876-5p accelerated tumor growth and enhanced stemness in HCC cells.

CONCLUSIONS

CD63-high macrophage-derived exosomes, particularly those enriched with miR-6876-5p, play a pivotal role in HCC progression by enhancing stemness and promoting epithelial-mesenchymal transition through the PTEN/Akt pathway. Targeting these exosomes and their microRNAs offers a promising therapeutic strategy forHCC.

摘要

目的

越来越多的证据表明,源自巨噬细胞外泌体的微小RNA可调节癌症的干性和进展。然而,肝癌细胞与肿瘤相关巨噬细胞之间的相互作用机制仍不清楚。

方法

从对照或CD63过表达巨噬细胞中提取外泌体,并与肝癌细胞共培养。评估肝癌细胞的干性、增殖、上皮-间质转化和体内致瘤性,以确定CD63高表达巨噬细胞衍生的外泌体miR-6876-5p在肝癌中的作用。还研究了miR-6876-5p与PTEN/Akt轴之间的结合关系。

结果

CD63表达升高与肝癌中肿瘤相关巨噬细胞浸润增加和预后较差相关。CD63高表达巨噬细胞衍生的外泌体增强了肝癌细胞的增殖、干性和上皮-间质转化。这些外泌体中的miR-6876-5p被确定为关键介质,通过靶向PTEN和激活Akt信号通路促进肝癌进展。体内研究证实,CD63高表达巨噬细胞衍生的外泌体miR-6876-5p加速了肿瘤生长并增强了肝癌细胞的干性。

结论

CD63高表达巨噬细胞衍生的外泌体,特别是富含miR-6876-5p的外泌体,通过增强干性并通过PTEN/Akt途径促进上皮-间质转化,在肝癌进展中起关键作用。靶向这些外泌体及其微小RNA为肝癌提供了一种有前景的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/84eff549a1b5/hc9-9-e0616-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/5920d9c401c5/hc9-9-e0616-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/75da3306ec1e/hc9-9-e0616-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/045a2408e95f/hc9-9-e0616-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/b338c32a3d5f/hc9-9-e0616-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/ea6481d559b7/hc9-9-e0616-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/0f772f02d512/hc9-9-e0616-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/2dcdf06a1918/hc9-9-e0616-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/84eff549a1b5/hc9-9-e0616-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/5920d9c401c5/hc9-9-e0616-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/75da3306ec1e/hc9-9-e0616-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/045a2408e95f/hc9-9-e0616-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/b338c32a3d5f/hc9-9-e0616-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/ea6481d559b7/hc9-9-e0616-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/0f772f02d512/hc9-9-e0616-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/2dcdf06a1918/hc9-9-e0616-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0d/11717501/84eff549a1b5/hc9-9-e0616-g008.jpg

相似文献

1
CD63-high macrophage-derived exosomal miR-6876-5p promotes hepatocellular carcinoma stemness via PTEN/Akt-mediated EMT pathway.CD63高表达的巨噬细胞来源外泌体miR-6876-5p通过PTEN/Akt介导的上皮-间质转化途径促进肝癌干性。
Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000616. eCollection 2025 Jan 1.
2
Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.外泌体 microRNA-32-5p 通过 PI3K/Akt 通路诱导肝癌多药耐药。
J Exp Clin Cancer Res. 2018 Mar 12;37(1):52. doi: 10.1186/s13046-018-0677-7.
3
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.高转移性癌细胞衍生的外泌体 miR92a-3p 通过调控肝癌中的 PTEN/Akt 通路促进低转移性癌细胞的上皮-间充质转化和转移。
Oncogene. 2020 Oct;39(42):6529-6543. doi: 10.1038/s41388-020-01450-5. Epub 2020 Sep 11.
4
Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.M2 巨噬细胞分泌的外泌体通过 miR-27a-3p/TXNIP 通路促进肝癌干细胞特性。
Int Immunopharmacol. 2021 Dec;101(Pt A):107585. doi: 10.1016/j.intimp.2021.107585. Epub 2021 Sep 30.
5
Oleanolic acid inhibits M2 macrophage polarization and potentiates anti-PD-1 therapy in hepatocellular carcinoma by targeting miR-130b-3p-PTEN-PI3K-Akt signaling and glycolysis.齐墩果酸通过靶向miR-130b-3p-PTEN-PI3K-Akt信号通路和糖酵解抑制M2巨噬细胞极化并增强肝细胞癌的抗PD-1治疗效果。
Phytomedicine. 2025 Jun;141:156750. doi: 10.1016/j.phymed.2025.156750. Epub 2025 Apr 9.
6
Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.肝癌细胞来源的外泌体 DLX6-AS1 通过微小 RNA-15a-5p/CXCL17 轴诱导 M2 型巨噬细胞极化促进肝癌迁移和侵袭
J Exp Clin Cancer Res. 2021 May 26;40(1):177. doi: 10.1186/s13046-021-01973-z.
7
MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.微小RNA-155-5p通过PI3K/Akt信号通路抑制PTEN从而促进肝细胞癌进展。
Cancer Sci. 2017 Apr;108(4):620-631. doi: 10.1111/cas.13177. Epub 2017 Apr 19.
8
Cancer-associated fibroblasts-secreted exosomal miR-92a-3p promotes tumor growth and stemness in hepatocellular carcinoma through activation of Wnt/β-catenin signaling pathway by suppressing AXIN1.癌相关成纤维细胞分泌的外泌体 miR-92a-3p 通过抑制 AXIN1 激活 Wnt/β-连环蛋白信号通路促进肝癌的肿瘤生长和干细胞特性。
J Cell Physiol. 2024 Sep;239(9):e31344. doi: 10.1002/jcp.31344. Epub 2024 Jul 1.
9
Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway.结直肠癌细胞来源的外泌体 miR-372-5p 通过 PTEN/AKT/NF-κB/PD-L1 通路诱导结直肠癌免疫逃逸。
Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113261. doi: 10.1016/j.intimp.2024.113261. Epub 2024 Sep 30.
10
Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.微小RNA-30a-5p的过表达通过靶向MTDH/PTEN/AKT通路抑制肝癌细胞增殖并诱导其凋亡。
Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.

引用本文的文献

1
Crosstalk between exosomes and tumor-associated macrophages in hepatocellular carcinoma: implication for cancer progression and therapy.肝细胞癌中外泌体与肿瘤相关巨噬细胞之间的串扰:对癌症进展和治疗的影响
Front Immunol. 2025 Apr 8;16:1512480. doi: 10.3389/fimmu.2025.1512480. eCollection 2025.

本文引用的文献

1
CD63 + tumor-associated macrophages drive the progression of hepatocellular carcinoma through the induction of epithelial-mesenchymal transition and lipid reprogramming.CD63+肿瘤相关巨噬细胞通过诱导上皮-间充质转化和脂质重编程推动肝癌的进展。
BMC Cancer. 2024 Jun 7;24(1):698. doi: 10.1186/s12885-024-12472-7.
2
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.阿替利珠单抗联合贝伐珠单抗对比主动监测用于治疗接受手术切除或消融治疗的高风险肝细胞癌患者(IMbrave050):一项随机、开放标签、多中心、III 期临床试验。
Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20.
3
PTEN activates chaperone-mediated autophagy to regulate metabolism.PTEN 通过激活伴侣蛋白介导的自噬来调节代谢。
Autophagy. 2024 Jan;20(1):216-217. doi: 10.1080/15548627.2023.2255966. Epub 2023 Sep 8.
4
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.派姆单抗对比安慰剂作为二线治疗用于亚洲晚期肝细胞癌患者:一项随机、双盲、III 期试验。
J Clin Oncol. 2023 Mar 1;41(7):1434-1443. doi: 10.1200/JCO.22.00620. Epub 2022 Dec 1.
5
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer.外泌体的生物发生:在癌症中的机制、调控和治疗意义。
Mol Cancer. 2022 Nov 1;21(1):207. doi: 10.1186/s12943-022-01671-0.
6
Macrophages as tools and targets in cancer therapy.巨噬细胞作为癌症治疗的工具和靶点。
Nat Rev Drug Discov. 2022 Nov;21(11):799-820. doi: 10.1038/s41573-022-00520-5. Epub 2022 Aug 16.
7
Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy.肿瘤来源的外泌体在癌症免疫微环境和癌症免疫治疗中的作用。
Cancer Lett. 2022 Nov 1;548:215823. doi: 10.1016/j.canlet.2022.215823. Epub 2022 Jul 12.
8
Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.肿瘤细胞和肿瘤相关巨噬细胞来源的外泌体非编码 RNA 在肿瘤微环境中的作用。
Mol Ther. 2022 Oct 5;30(10):3133-3154. doi: 10.1016/j.ymthe.2022.01.046. Epub 2022 Apr 9.
9
Clinical relevance of tumour-associated macrophages.肿瘤相关巨噬细胞的临床相关性。
Nat Rev Clin Oncol. 2022 Jun;19(6):402-421. doi: 10.1038/s41571-022-00620-6. Epub 2022 Mar 30.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.